🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: * The p53 gene normally helps to stop cancer cells from growin...
Status
Withdrawn
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2011-06-15
Trial ID
NCT01386502
Treatments Being Tested
RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Status
Completed
Location
Medicine Branch
Start Date
1996-02
Trial ID
NCT00019084
The aim of the study is to show if vaccination with autologous dendritic ce...
Status
Completed
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Start Date
2004-09
Trial ID
NCT00197912
Treatments Being Tested
The purpose of this study is to find out what effects (good and bad) immuno...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-03-15
Trial ID
NCT03406715
Treatments Being Tested
The ability of chemotherapy to cure cancer, including breast cancer, has be...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1995-07
Trial ID
NCT00001440
Treatments Being Tested
RATIONALE: Vaccines made from a person's dendritic cells mixed with peptide...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2005-09
Trial ID
NCT00404339
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
NCI - Center for Cancer Research
Start Date
2000-06
Trial ID
NCT00019916
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2000-08
Trial ID
NCT00019929
Treatments Being Tested
The purpose of this study is to determine whether the addition of cyclophos...
Status
Completed
Location
University Medical Centre Groningen
Start Date
2008-10
Trial ID
NCT00844506
Treatments Being Tested
Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive ...
Status
Recruiting
Location
Clinical Research Advisors, LLC
Start Date
2024-12-03
Trial ID
NCT06472245
Treatments Being Tested